Abstract 5163: Characterization of NMS-E194, a selective and potent PERK inhibitor with efficacy in the KMS-11 multiple myelomaClaudia Perrera, Barbara Valsasina, Stefania Re Depaolini et al.|Cancer Research|2017Cited by 1
517 Identification and characterization of selective MELK kinase inhibitorsPatrizia Carpinelli, Arturo Galvani, Nadia Amboldi et al.|European Journal of Cancer|2014Cited by 0
Abstract 3795: Novel and selective MELK kinase inhibitors active in breast cancer cell linesPatrizia Carpinelli, Alessia Montagnoli, Marisa Montemartini et al.|Cancer Research|2016Cited by 0